Close this window

Transaction in Own Shares

09/08/2026
RNS Number : 6571T
Fevertree Drinks PLC
08 September 2026
 

8th September 2026                               

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 1st September to 4th September 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

01 September 2026

XLON

840.8030

33,496

831.5000

852.5000

01 September 2026

AIMX

838.5000

16,760

838.5000

838.5000

02 September 2026

XLON

829.9916

25,786

825.5000

838.0000

02 September 2026

AIMX

829.0000

15,000

829.0000

829.0000

03 September 2026

XLON

818.6811

15,888

810.0000

838.5000

03 September 2026

AIMX

817.7170

32,851

817.0000

820.0000

04 September 2026

XLON

824.5365

12,072

817.0000

831.0000

04 September 2026

AIMX

817.7500

25,000

817.7500

817.7500

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/6571T_1-2026-9-7.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDDLBBQKLEBBD

Multimedia Files:

Close this window